Poland· PL-100043207
Methotrexat-Ebewe
A methotrexate product containing methotrexatum, registered in Poland by Ebewe Pharma Ges.m.b.H Nfg. KG. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Methotrexate is registered in 12 of 19 countries.
Countries holding a registration under ATC L01BA01 (methotrexate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Methotrexate · ATC L01BA01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Methotrexatum
- Manufacturer
- Ebewe Pharma Ges.m.b.H Nfg. KG
- Country
- Poland (PL)
- ATC code
- L01BA01
- ATC class
- Methotrexate
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990333417
- gtin05909990333424
- gtin05907626708295
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
949 interactions on record for methotrexate.
Graded by severity as the source publishes them — 107 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methotrexate · interactions on record
949 records
- 107 severe
- 466 moderate
- 17 minor
- 309 info
Most severe, free to view
- OmeprazoleA02BC01severe
- PantoprazoleA02BC02severe
- LansoprazoleA02BC03severe
- RabeprazoleA02BC04severe
50 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methotrexate in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandMethrexx 10 mg/1 ml, Injektionslösung in einer FertigspritzeSandoz Pharmaceuticals AG
- SpainBERTANEL 10 mg/1 ml SOLUCION INYECTABLE EN JERINGA PRECARGADAEbewe Pharma Ges.M.B.H. Nfg.Kg
- FinlandEbetrexEbewe Pharma Ges.m.b.H. Nfg.KG
- BelgiumEbetrexat 10 mg/mlEbewe Pharma GesmbH Nfg KG
- CzechiaFOXIEMOeasyMed s.r.o., Praha 10
- United KingdomEbetrex 10mg/1ml solution for injection pre-filled syringesSandoz Ltd
- NetherlandsBasitrin 10 mg=0,267 ml, oplossing voor injectie in een voorgevulde spuit 37,5 mg/mlBasic Pharma Manufacturing B.V.
- SwedenEbetrex 2,5 mg TablettEBEWE Pharma Ges.m.b.H.Nfg.KG
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Ebetrexat, Methofill
- Belgium · Basitrin, Emthexate
- Bulgaria · Ebetrexat, Инжексат
- Cyprus · Injexate, Methotrexate Accord
- Czechia · Foxiemo, Injexate
- Germany · Lantarel, Lantarel Fs
- Denmark · Ebetrex, Emthexate
- Estonia · Ebetrex, Metex
- Spain · Bertanel, Imeth
- Finland · Ebetrex, Injexate
- France · Imenor, Imeth
- United Kingdom (Northern Ireland) · Ebetrex, Injexate
- Greece · Methobion, Methotrexate Pfizer
- Croatia · Ebetrexat, Methofill
- Hungary · Ebetrexat, Methofill
- Ireland · Methofill, Methotrexate Abcur
- Iceland · Jylamvo, Methotrexat Ebewe
- Italy · Afslamet, Immutrex
- Liechtenstein · Jylamvo, Nordimet
- Lithuania · Ebetrexat, Metex
- Luxembourg · Emthexate, Emthexate Teva Pharma
- Latvia · Ebetrex, Metex
- Malta · Methotrexate Aspire Pharma (Malta)
- Netherlands · Basitrin, Ebetrex
- Norway · Ebetrex, Jylamvo
- Portugal · Fauldexato, Ledertrexato
- Romania · Methotrexat Ebewe, Metorthrit
- Sweden · Ebetrex, Injexate
- Slovenia · Methofill, Metoject
- Slovakia · Foxiemo, Injexate
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/07febf1a-c275-4c28-ab3d-d96c77eef3e3 GET /v1/drugs/07febf1a-c275-4c28-ab3d-d96c77eef3e3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "10 mg/ml",
"packaging": "05909990333417 ¦ Rp ¦ 6472\n10 fiol. 1 ml\n05909990333424 ¦ Rp ¦ 16243\n5 fiol. 5 ml\n05907626708295 ¦ Rp ¦ 125126\n1 fiol. 5 ml",
"substance": "Methotrexatum 10 mg",
"common_name": "Methotrexatum",
"pl_product_id": "100043207",
"pozwolenie_nr": "03334",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about methotrexate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.